SCHEMBL4132815

SCHEMBL4132815

CC(C)OCCCN(Cc1ccc(F)cc1)c1nc2c(C(C)(C)C)nn(C)c2c(=O)[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
POLB P06746 2/20 0.36
LMNA P02545 2/20 0.34
HTT P42858 1/20 0.34
HIF1A Q16665 1/20 0.34
MCOLN3 Q8TDD5 1/20 0.34
KMT2A Q03164 1/20 0.32
TP53 P04637 1/20 0.30
PDE2A O00408 4/20 0.30
PDE6D O43924 1/20 0.30
PDE5A O76074 1/20 0.30
PDE6A P16499 1/20 0.30
PDE6G P18545 1/20 0.30
PDE4A P27815 1/20 0.30
PDE6B P35913 1/20 0.30
PDE6C P51160 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4893657 0.85 KDM4E (0.43) KDM4EALDH1A1NPSR1MAPTSMN1; SMN2
SCHEMBL4131950 0.82 GAA (0.41) KDM4EALDH1A1NPSR1MAPTSMN1; SMN2
SCHEMBL4117755 0.78 KDM4E (0.41) KDM4EALDH1A1NPSR1MAPTSMN1; SMN2
SCHEMBL4904083 0.71 KDM4E (0.48) KDM4EALDH1A1NPSR1MAPTSMN1; SMN2
SCHEMBL4898303 0.70 PDE5A (0.48) KDM4EALDH1A1POLBKMT2APDE5A
SCHEMBL3996853 0.69 GAA (0.42) KDM4EALDH1A1SMN1; SMN2POLBLMNA
SCHEMBL14021008 0.68 KDM4E (0.40) KDM4EALDH1A1NPSR1MAPTSMN1; SMN2
SCHEMBL4125332 0.68 PDE5A (0.46) KDM4EALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL14021139 0.67 KDM4E (0.38) KDM4EALDH1A1NPSR1MAPTSMN1; SMN2
SCHEMBL4901385 0.67 KDM4E (0.44) KDM4EALDH1A1NPSR1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed